These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3537009)

  • 21. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy.
    Donga E; van Dijk M; Hoogma RP; Corssmit EP; Romijn JA
    Diabetes Metab Res Rev; 2013 Jan; 29(1):33-8. PubMed ID: 22936679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow.
    Baron AD; Laakso M; Brechtel G; Edelman SV
    J Clin Endocrinol Metab; 1991 Sep; 73(3):637-43. PubMed ID: 1874938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects.
    Sigal RJ; Purdon C; Fisher SJ; Halter JB; Vranic M; Marliss EB
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1049-57. PubMed ID: 7962273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U; Müller R; Berger W
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus.
    Nyholm B; Møller N; Gravholt CH; Orskov L; Mengel A; Bryan G; Moyses C; Alberti KG; Schmitz O
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1083-9. PubMed ID: 8772580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hyperglycemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C]glucose.
    Bell PM; Firth RG; Rizza RA
    Diabetes; 1986 Jun; 35(6):642-8. PubMed ID: 3519321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin action is normalized in newly diagnosed type I diabetic patients after three months of insulin treatment.
    Nijs HG; Radder JK; Frölich M; Krans HM
    Metabolism; 1988 May; 37(5):473-8. PubMed ID: 3285134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased glucose carbon recycling in severely insulin deficient type 1 (insulin-dependent) diabetic subjects.
    Benn JJ; Rai R; Sönksen PH
    Diabetologia; 1990 Mar; 33(3):158-62. PubMed ID: 2184067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Apr; 58(4):659-66. PubMed ID: 6365945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No evidence for isotope discrimination of tritiated glucose tracers in measurements of glucose turnover rates in man.
    Koivisto VA; Yki-Järvinen H; Puhakainen I; Virkamäki A; Kolaczynski J; DeFronzo R
    Diabetologia; 1990 Mar; 33(3):168-73. PubMed ID: 2184069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of insulin and amino acids on leg protein turnover in IDDM patients.
    Bennet WM; Connacher AA; Jung RT; Stehle P; Rennie MJ
    Diabetes; 1991 Apr; 40(4):499-508. PubMed ID: 2010051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose turnover in presence of changing glucose concentrations: error analysis for glucose disappearance.
    Caumo A; Homan M; Katz H; Cobelli C; Rizza R
    Am J Physiol; 1995 Sep; 269(3 Pt 1):E557-67. PubMed ID: 7573434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Underestimation of hepatic glucose production by radioactive and stable tracers.
    Argoud GM; Schade DS; Eaton RP
    Am J Physiol; 1987 May; 252(5 Pt 1):E606-15. PubMed ID: 3555113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isotope turnover studies in uncontrolled diabetes and the effects of insulin.
    Saunders J; Boroujerdi MA; Brown PM; Carsons ER; Hall SE; Umpleby AM; Sönksen PH
    Ciba Found Symp; 1982; 87():273-92. PubMed ID: 7042241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of brain glucose metabolism in diabetes as measured by positron emission tomography or by arteriovenous techniques.
    Grill V
    Ann Med; 1990 Jun; 22(3):171-6. PubMed ID: 2393552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.